Learn About Hemorrhagic Proctocolitis

What is the definition of Hemorrhagic Proctocolitis?
Hemorrhagic proctocolitis is a condition in which there is inflammation in the lining of the colon and rectum that causes bleeding. Hemorrhagic proctocolitis has many possible causes.
Save information for later
Sign Up
What are the symptoms of Hemorrhagic Proctocolitis?
Symptoms of hemorrhagic proctocolitis may include abdominal cramps, diarrhea, rectal and colon inflammation, gastrointestinal bleeding, increased bowel movements, a feeling of fullness in rectum, rectal bleeding, rectal pain, pain of the left side of abdomen, pain with bowel movements, blood in the stool, blackened stool, mucus in stool, and anemia.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hemorrhagic Proctocolitis?
Treatment for hemorrhagic proctocolitis depends on the cause and may include antibiotics, antiviral agents, anti-inflammatory medications, medications to ease bowel movements, and probiotics.
Who are the top Hemorrhagic Proctocolitis Local Doctors?
DR
David T. Rubin
Dr. David T. Rubin
Gastroenterology | Internal Medicine
Elite
Highly rated in
17
conditions
Gastroenterology
Internal Medicine

UChicago Medicine River East

355 E Grand Ave, 
Chicago, IL 

David Rubin is a Gastroenterologist and an Internal Medicine expert in Chicago, Illinois. Rubin has been practicing medicine for over 28 years and is rated as an Elite expert by MediFind in the treatment of Hemorrhagic Proctocolitis. He is also highly rated in 17 other conditions, according to our data. His top areas of expertise are Ulcerative Colitis, Viral Gastroenteritis, Crohn's Disease, Endoscopy, and Colonoscopy. He is licensed to treat patients in Illinois. Rubin is currently accepting new patients.

DH
David P. Hudesman
Dr. David P. Hudesman
Gastroenterology | Internal Medicine
Elite
Highly rated in
5
conditions
Gastroenterology
Internal Medicine

NYU Langone Inflammatory Bowel Disease Center

305 E 33rd St, 
New York, NY 

David Hudesman is a Gastroenterologist and an Internal Medicine expert in New York, New York. Hudesman has been practicing medicine for over 17 years and is rated as an Elite expert by MediFind in the treatment of Hemorrhagic Proctocolitis. He is also highly rated in 5 other conditions, according to our data. His top areas of expertise are Ulcerative Colitis, Hemorrhagic Proctocolitis, Crohn's Disease, Endoscopy, and Colonoscopy. He is licensed to treat patients in New York. Hudesman is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn more
SH
Stephen B. Hanauer
Dr. Stephen B. Hanauer
Gastroenterology | Internal Medicine
Elite
Highly rated in
10
conditions
Gastroenterology
Internal Medicine

Northwestern Medicine Digestive Health Center

259 E Erie St, 
Chicago, IL 

Stephen Hanauer is a Gastroenterologist and an Internal Medicine expert in Chicago, Illinois. Hanauer has been practicing medicine for over 49 years and is rated as an Elite expert by MediFind in the treatment of Hemorrhagic Proctocolitis. He is also highly rated in 10 other conditions, according to our data. His top areas of expertise are Crohn's Disease, Ulcerative Colitis, Viral Gastroenteritis, Ileostomy, and Colonoscopy. He is licensed to treat patients in Illinois. Hanauer is currently accepting new patients.

View All Doctors
What are the latest Hemorrhagic Proctocolitis Clinical Trials?
Place of the QuantiFERON-CMV (QF-CMV) Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis (UC)
Who is this study for: Patients with ulcerative colitis
Enrollment Status: Recruiting
Publish Date: April 15, 2022
Intervention Type: Procedure, Biological
Study Phase: Not Applicable

Summary: CytoMegaloVirus (CMV) infection impairs evolution of Ulcerative Colitis (UC) leading to more severe and resistant to immunosuppressive therapies flare-up. CytoMegaloVirus (CMV) reactivation is assessed by the quantification of the CytoMegaloVirus (CMV) DeoxyriboNucleic Acid (DNA) load by real-time PCR (qPCR) in colonic biopsies; this assay is invasive and costly. The QuantiFERON-CytoMegaloVirus (Q...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Inflammatory Bowel Diseases Remission Registry
Enrollment Status: Recruiting
Publish Date: August 04, 2021

Summary: The inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and Crohn's disease (CD), are characterized by lifelong relapsing-remitting gastrointestinal inflammation, with symptoms of abdominal pain, diarrhea, and rectal bleeding during active disease. Medical therapy reduces intestinal inflammation and ameliorates symptoms. Clinical remission is defined when symptoms are resolved. In these pe...

View All Clinical Trials
What are the Latest Advances for Hemorrhagic Proctocolitis?
Efficacy and safety of vedolizumab for inflammatory bowel diseases: A systematic review and meta-analysis of randomized controlled trials.
Condition: Inflammatory Bowel Diseases
Journal: Medicine
Treatment Used: Vedolizumab
Number of Patients: 4268
Published: October 12, 2022
Endoscopic Treatment of Postoperative Bleeding, Bezoars, and Foreign Bodies.
Condition: Postoperative Bleeding, Bezoars, and Foreign Bodies
Journal: Gastrointestinal endoscopy clinics of North America
Treatment Used: Endoscopic Treatment
Number of Patients: 0
Published: October 06, 2022
Tired of the same old research?
Check Latest Advances
Principles, Preparation, Indications, Precaution, and Damage Control of Endoscopic Therapy in Inflammatory Bowel Disease.
Condition: Inflammatory Bowel Disease (IBD)
Journal: Gastrointestinal endoscopy clinics of North America
Treatment Used: Endoscopic Therapy
Number of Patients: 0
Published: October 06, 2022
View All Latest Advances